These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 9510150)
1. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. Kline JN; Waldschmidt TJ; Businga TR; Lemish JE; Weinstock JV; Thorne PS; Krieg AM J Immunol; 1998 Mar; 160(6):2555-9. PubMed ID: 9510150 [TBL] [Abstract][Full Text] [Related]
3. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides. Sur S; Wild JS; Choudhury BK; Sur N; Alam R; Klinman DM J Immunol; 1999 May; 162(10):6284-93. PubMed ID: 10229876 [TBL] [Abstract][Full Text] [Related]
4. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome. Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938 [TBL] [Abstract][Full Text] [Related]
5. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway. Xu W; Tamura T; Takatsu K Int Immunopharmacol; 2008 Feb; 8(2):351-61. PubMed ID: 18182251 [TBL] [Abstract][Full Text] [Related]
6. Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice. Zhu FG; Kandimalla ER; Yu D; Tang JX; Agrawal S Int Immunopharmacol; 2004 Jul; 4(7):851-62. PubMed ID: 15182725 [TBL] [Abstract][Full Text] [Related]
7. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung. Ashino S; Wakita D; Zhang Y; Chamoto K; Kitamura H; Nishimura T Int Immunol; 2008 Feb; 20(2):259-66. PubMed ID: 18156622 [TBL] [Abstract][Full Text] [Related]
8. Co-administration of CpG oligonucleotides and chenopodium album extract reverse IgG2a/IgG1 ratios and increase IFN-gamma and IL-10 productions in a murine model of asthma. Mousavi T; Salek Moghadam A; Falak R; Tebyanian M Iran J Allergy Asthma Immunol; 2008 Mar; 7(1):1-6. PubMed ID: 18322305 [TBL] [Abstract][Full Text] [Related]
9. An antigen-independent but not antigen-specific T(H)1 response provides protection in the murine airway inflammation model. Burger MS; Zuleger CL; Chu Q; Gao X; Payne LG; Chen D J Allergy Clin Immunol; 2004 Dec; 114(6):1301-8. PubMed ID: 15577827 [TBL] [Abstract][Full Text] [Related]
10. Effect of an orally active Th1/Th2 balance modulator, M50367, on IgE production, eosinophilia, and airway hyperresponsiveness in mice. Kato Y; Manabe T; Tanaka Y; Mochizuki H J Immunol; 1999 Jun; 162(12):7470-9. PubMed ID: 10358202 [TBL] [Abstract][Full Text] [Related]
11. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model. Cho YS; Kwon B; Lee TH; Kim TB; Moon KA; La S; Lee J; Lee SD; Oh YM; Moon HB Clin Exp Allergy; 2006 Mar; 36(3):377-85. PubMed ID: 16499650 [TBL] [Abstract][Full Text] [Related]
12. Use of CpG oligonucleotides in treatment of asthma and allergic disease. Fonseca DE; Kline JN Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442 [TBL] [Abstract][Full Text] [Related]
13. Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model. Kootiratrakarn T; Fujimura T; Sano K; Okuyama R; Aiba S; Tagami H; Terui T Eur J Immunol; 2005 Nov; 35(11):3277-86. PubMed ID: 16245360 [TBL] [Abstract][Full Text] [Related]
14. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses. Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of Chenopodium album induced asthma by intranasal administration of CpG oligodeoxynucleotides in BALB/c mice. Mousavi T; Salek Moghadam A; Falak R Iran J Immunol; 2008 Mar; 5(1):57-63. PubMed ID: 18319526 [TBL] [Abstract][Full Text] [Related]
16. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. Zimmermann S; Egeter O; Hausmann S; Lipford GB; Röcken M; Wagner H; Heeg K J Immunol; 1998 Apr; 160(8):3627-30. PubMed ID: 9558060 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant effect of synthetic oligodeoxyribonucleotides (CpG-ODN) from the Paracoccidioides brasiliensis gp43 gene on the Th2-Th1 immunomodulation of experimental paracoccidioidomycosis. Amaral CC; Garcia IP; Fernandes GF; Almeida SR; Camargo ZP; Souza MC Scand J Immunol; 2005 Oct; 62(4):325-33. PubMed ID: 16253119 [TBL] [Abstract][Full Text] [Related]
18. The enhanced effect of a hexameric deoxyriboguanosine run conjugation to CpG oligodeoxynucleotides on protection against allergic asthma. Park Y; Chang YS; Lee SW; Cho SY; Kim YK; Min KU; Kim YY; Cho SH; Sung YC J Allergy Clin Immunol; 2001 Oct; 108(4):570-6. PubMed ID: 11590383 [TBL] [Abstract][Full Text] [Related]
19. A prophylactic effect of an oligodeoxynucleotide containing a cytidine-guanosine motif against Japanese cedar pollen-induced T-helper type 2 allergic response. Liu B; Zhang L; Liu J; Shan F; Wang E; Kimura Y J Asthma; 2011 Nov; 48(9):974-8. PubMed ID: 21967528 [TBL] [Abstract][Full Text] [Related]